Skip to main content

Scavilla Daniel T's Form 4 filing

Globus Medical Inc (GMED) · filed Nov 25, 2024

Accession no.
0000950170-24-130588
Filed
Nov 25, 2024
Trade date
Nov 21, 2024
Filing delay
4 days
Rule 10b5-1 plan
Checked

This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $11.1M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Scavilla Daniel TCIK 0001642439Director, Officer (President, CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 21, 2024Class A Common StockMOption exerciseAcquired+50,000$43.77+$2,188,50050,000Direct
Nov 21, 2024Class A Common StockMOption exerciseAcquired+80,000$43.58+$3,486,400130,000Direct
Nov 21, 2024Class A Common StockSSaleDisposed−130,000$85.00−$11,050,0000Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Nov 21, 2024Class A Common StockMOption exerciseDisposed−50,000$0.00$00Direct
Nov 21, 2024Class A Common StockMOption exerciseDisposed−80,000$0.00$00Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)